UK doctors think Britain’s exit from the European Union will be very bad for the NHS, reveal the results of a study from UCL, the London School of Hygiene & Tropical Medicine (LSHTM) and Queen Mary University of London.
A new drug to delay the spread of ovarian cancer, which was developed from UCL research, has been licensed for use in the UK.
The unique forum convening public and private sector leaders for networking, intelligence and debates on research and innovation.
These updates are republished press releases and communications from members of the Science|Business Network
Tweets by scibus